Nevro Corp. (NYSE:NVRO) Receives $6.43 Consensus Target Price from Brokerages
Nevro Corp. (NYSE:NVRO – Get Free Report) has earned a consensus rating of “Reduce” from the thirteen research firms that are ...
The Victoria Advocate11d
Nevro Reports Fourth-Quarter and Full-Year 2024 Financial Results
Nevro's comprehensive HFX™ spinal cord stimulation (SCS) platform includes the Senza® SCS system and support services for the treatment of chronic pain of the trunk and limb and painful ...
Nevro Q4 Earnings & Revenues Beat Estimates, Gross Margin Down
NVRO's fourth-quarter earnings surpass the Zacks Consensus Estimate, while worldwide revenues decline year over year. The ...
Nevro Reports Fourth-Quarter and Full-Year 2024 Financial Results
Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the ...
Mena FN11d
Nevro Reports Fourth-Quarter And Full-Year 2024 Financial Results
REDWOOD CITY, Calif., March 4, 2025 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO ), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of ...
Nevro Corp.: Nevro Reports Fourth-Quarter and Full-Year 2024 Financial Results
Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions ...